首页> 中国专利> 一种治疗小儿骨折术后创面感染的药物组合物

一种治疗小儿骨折术后创面感染的药物组合物

页面导航

摘要
著录项
法律信息
相似文献

摘要

本发明涉及一种治疗小儿骨折术后创面感染的药物组合物，它由下列重量份的物质制成：乳香1-10份、积雪草1-10份、葫芦藤10-20份、杜仲5-15份、甘草1-10份、香艾1-10份、马蹬草5-15份、地榆5-15份、小果蔷薇叶1-10份、金银花10-20份、问荆1-10份、三七5-15份、山蒟5-15份、龙舌草10-20份、白茅根1-10份、羊耳蒜1-10份、红花5-15份、僵蚕1-10份、头巾草10-20份、壮筋草5-15份、佛肚花5-15份、血竭1-10份。本发明所述的药物组合物配伍合理，治疗小儿骨折术后创面感染效果显著，值得临床应用和推广。

著录项

公开/公告号CN104524316B

专利类型发明专利
公开/公告日2016-03-23

原文格式PDF
申请/专利权人姜福恺;
展开▼

申请/专利号CN201510037211.7
发明设计人姜福恺;李静;
展开▼

申请日2015-01-25
分类号A61K36/899(20060101);A61P17/02(20060101);A61P31/00(20060101);A61P29/00(20060101);A61K35/64(20150101);
代理机构北京高航知识产权代理有限公司;
代理人鲁华
地址 266000 山东省青岛市平度中医医院
入库时间 2022-08-23 09:36:41

法律信息

法律状态公告日

法律状态信息

法律状态
2019-12-03

专利权的转移 IPC(主分类):A61K36/899 登记生效日:20191114 变更前: 变更后: 申请日:20150125

专利申请权、专利权的转移
2018-08-14

专利权的转移 IPC(主分类):A61K36/899 登记生效日:20180725 变更前: 变更后: 申请日:20150125

专利申请权、专利权的转移
2017-08-25

专利权的转移 IPC(主分类):A61K36/899 登记生效日:20170804 变更前: 变更后: 申请日:20150125

专利申请权、专利权的转移
2017-08-25

著录事项变更 IPC(主分类):A61K36/899 变更前: 变更后: 申请日:20150125

著录事项变更
2016-03-23

授权

授权
2016-03-16

著录事项变更 IPC(主分类):A61K36/899 变更前: 变更后: 申请日:20150125

著录事项变更
2016-03-16

专利申请权的转移 IPC(主分类):A61K36/899 登记生效日:20160224 变更前: 变更后: 申请日:20150125

专利申请权、专利权的转移
2015-11-11

著录事项变更 IPC(主分类):A61K36/899 变更前: 变更后: 申请日:20150125

著录事项变更
2015-05-20

实质审查的生效 IPC(主分类):A61K36/899 申请日:20150125

实质审查的生效
2015-04-22

公开

公开

查看全部

相似文献

专利
中文文献
外文文献

1. 一种治疗小儿骨折术后创面感染的药物组合物 [P] . 中国专利： CN104524316B . 2016.03.23
2. 一种治疗小儿骨折术后创面感染的药物组合物 [P] . 中国专利： CN105079570A . 2015-11-25
3. compound, process for preparing same, pharmaceutical composition, methods for inhibiting dipeptidyl peptidase-iv, for treating conditions mediated by inhibition of dipeptidyl peptidase-iv, increased islet neogenesis, b-cell survival, and insulin biosynthesis in a mammalian patient, and a disease or condition, to treat, control, or prevent diabetes, hyperglycemia, obesity, insulin resistance, one or more disorders, atherosclerosis, one or more conditions in a mammalian patient, neutropenia, and anemia, to treat or control growth hormone deficiency and hiv infection in a mammalian patient, modulate the immune response in a mammalian patient, reduce sperm motility, and produce a pharmaceutical composition, and, pharmaceutical combination [P] . BRPI0416444A . 2007-02-27

机译：化合物，其制备方法，药物组合物，抑制二肽基肽酶-iv的方法，用于治疗由抑制二肽基肽酶-iv介导的疾病，提高的胰岛新生，b细胞存活和胰岛素生物合成的疾病的患者治疗或控制糖尿病，高血糖，肥胖，胰岛素抵抗，一种或多种疾病，动脉粥样硬化，哺乳动物患者的一种或多种疾病，中性粒细胞减少和贫血的一种或多种疾病，以治疗或控制生长激素缺乏症和艾滋病毒感染在哺乳动物患者中，调节哺乳动物患者的免疫反应，减少精子运动，并产生药物组合物，以及药物组合
4. composition, pharmaceutical composition, effervescent dosage form, multiple unit oral oral pharmaceutical composition, extended release pharmaceutical dosage form, enteric coated pharmaceutical dosage form, stable pharmaceutical dosage form for oral administration to mammalian subjects, method for treating diseases acid-related diseases by inhibiting gastric acid secretion, method for treating a bacterial infection caused or caused by helicobacter pylori, process for preparing a compound of formula 3, process for preparing a compound of formula 5, use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion, use of a compound of formula 1 for the preparation of a medicament for treating a bacterial infection caused or caused by helicobacter pyl or use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion [P] . BRPI0617987A2 . 2011-08-16

机译：组合物，药物组合物，泡腾剂型，多单位口服口服药物组合物，缓释药物剂型，肠溶衣药物剂型，向哺乳动物受试者口服给药的稳定药物剂型，通过抑制胃酸治疗疾病的方法酸分泌，治疗由幽门螺杆菌引起或引起的细菌感染的方法，制备式3化合物的方法，制备式5化合物的方法，式1化合物在制备用于治疗胃的药物中的用途通过抑制胃酸分泌来治疗与酸有关的疾病，将式1的化合物用于制备用于治疗由幽门螺杆菌引起或引起的细菌感染的药物，或将式1的化合物用于制备用于治疗的药物通过抑制胃酸分泌来治疗胃酸相关疾病
5. pencicillin-binding protein, nucleic acid, antibody or antibody fragment, medicament, pharmaceutical composition, uses of at least one penicillin-binding protein or fragment or variant or fragment thereof, of at least one nucleic acid and of at least one antibody or antibody fragment, in vitro antibody detection methods directed against neisseria meningitidis infection from a penicillin-binding protein, nucleic acid, antibody or an antibody fragment, pharmaceutical composition of at least one penicillin-binding protein or fragment or variant or variant thereof, of at least one nucleic acid and at least one antibody directed against neisseria meningitidis infection from a biological sample of a mammal and in vitro diagnosis of neisseria miningitidis infection from a biological sample from a mammal and monoclonal antibody [P] . BRPI0610802A2 . 2016-11-16

机译：青霉素结合蛋白，核酸，抗体或抗体片段，药物，药物组合物，至少一种青霉素结合蛋白或其片段或变异体或片段，至少一种核酸和至少一种抗体或抗体片段的用途，针对脑膜炎奈瑟菌的青霉素结合蛋白，核酸，抗体或抗体片段感染的体外抗体检测方法，至少一种青霉素结合蛋白或其片段或变异体或变异体，至少一种核酸的药物组合物酸和至少一种针对哺乳动物生物样品中脑膜炎奈瑟氏菌感染的抗体以及来自哺乳动物生物样品中的矿业性奈瑟氏球菌感染的体外诊断和单克隆抗体